Arcturus Therapeutics Holdings Inc.
ARCT
$14.74
-$0.89-5.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -159.10% | -91.56% | 3.09% | -94.81% | 46.68% |
| Total Depreciation and Amortization | -17.46% | -17.85% | -16.73% | -16.34% | -14.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.17% | -35.78% | -0.39% | -39.15% | -35.51% |
| Change in Net Operating Assets | 71.21% | 109.01% | -83.11% | 62.27% | 84.43% |
| Cash from Operations | -245.96% | 44.67% | -5,613.73% | 27.83% | 80.91% |
| Capital Expenditure | -- | -- | -- | -126.25% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 124.82% | -- | -126.25% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -91.79% | 8,622.39% | 76.77% | -88.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -99.89% | 8,622.39% | 76.77% | -712.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.88% | 3.43% | -2,867.33% | 30.43% | 27.03% |